Generation of these two new engineered adenovirus vectors was based on the hypothesis that suppression of HMGA1 synthesis in cancer cells would potentially provide stronger anti-cancer activity compared to infection with adenoviral vectors exhibiting HMGA1 sequestration capability alone. Here, HMGA1 is linked to cancer.